These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 35788082)
41. Computed Tomography-Detected Central Lymph Node Metastasis in Ultrasonography Node-Negative Papillary Thyroid Carcinoma: Is It Really Significant? Kim SK; Woo JW; Park I; Lee JH; Choe JH; Kim JH; Kim JS Ann Surg Oncol; 2017 Feb; 24(2):442-449. PubMed ID: 27624581 [TBL] [Abstract][Full Text] [Related]
42. Computed Tomography for Detecting Cervical Lymph Node Metastasis in Patients Who Have Papillary Thyroid Microcarcinoma with Tumor Characteristics Appropriate for Active Surveillance. Lee DH; Kim YK; Yu HW; Choi JY; Park SY; Moon JH Thyroid; 2019 Nov; 29(11):1653-1659. PubMed ID: 31436140 [No Abstract] [Full Text] [Related]
43. The accuracy of ultrasonography in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: A meta-analysis. Wu LM; Gu HY; Qu XH; Zheng J; Zhang W; Yin Y; Xu JR Eur J Radiol; 2012 Aug; 81(8):1798-805. PubMed ID: 21536396 [TBL] [Abstract][Full Text] [Related]
44. Radiomics diagnostic performance in predicting lymph node metastasis of papillary thyroid carcinoma: A systematic review and meta-analysis. HajiEsmailPoor Z; Kargar Z; Tabnak P Eur J Radiol; 2023 Nov; 168():111129. PubMed ID: 37820522 [TBL] [Abstract][Full Text] [Related]
45. Value of dual-phase, contrast-enhanced CT combined with ultrasound for the diagnosis of metastasis to central lymph nodes in patients with papillary thyroid cancer. Liu Y; Li S; Yan C; He C; Yun M; Liu M; Zhou J; Liu L Clin Imaging; 2021 Jul; 75():5-11. PubMed ID: 33486150 [TBL] [Abstract][Full Text] [Related]
46. Clinical Study of Ultrasonographic Risk Factors for Central Lymph Node Metastasis of Papillary Thyroid Carcinoma. Guang Y; He W; Zhang W; Zhang H; Zhang Y; Wan F Front Endocrinol (Lausanne); 2021; 12():791970. PubMed ID: 34917039 [TBL] [Abstract][Full Text] [Related]
47. Radiomics analysis of dual-energy CT-derived iodine maps for diagnosing metastatic cervical lymph nodes in patients with papillary thyroid cancer. Zhou Y; Su GY; Hu H; Ge YQ; Si Y; Shen MP; Xu XQ; Wu FY Eur Radiol; 2020 Nov; 30(11):6251-6262. PubMed ID: 32500193 [TBL] [Abstract][Full Text] [Related]
48. Factors associated with positive F-18 flurodeoxyglucose positron emission tomography before thyroidectomy in patients with papillary thyroid carcinoma. Kim BS; Kim SJ; Kim IJ; Pak K; Kim K Thyroid; 2012 Jul; 22(7):725-9. PubMed ID: 22524470 [TBL] [Abstract][Full Text] [Related]
49. High Iodine Nutrition May Be a Risk Factor for Cervical Lymph Node Metastasis in Papillary Thyroid Cancer Patients. Fan L; Tian Q; Xiu C; Wang F; Yuan Z; He Q; Guo L; Sun Q; Yang X; Miao S; Sun J; Sun D Ann Nutr Metab; 2021; 77(2):90-99. PubMed ID: 34289482 [TBL] [Abstract][Full Text] [Related]
50. Conventional Ultrasound, Immunohistochemical Factors and BRAF Chen J; Li XL; Zhao CK; Wang D; Wang Q; Li MX; Wei Q; Ji G; Xu HX Ultrasound Med Biol; 2018 Nov; 44(11):2296-2306. PubMed ID: 30100099 [TBL] [Abstract][Full Text] [Related]
51. Preoperative Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma via Conventional and Contrast-Enhanced Ultrasound. Tao L; Zhou W; Zhan W; Li W; Wang Y; Fan J J Ultrasound Med; 2020 Oct; 39(10):2071-2080. PubMed ID: 32352187 [TBL] [Abstract][Full Text] [Related]
52. Clinical risk factors for central lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis. Qu H; Sun GR; Liu Y; He QS Clin Endocrinol (Oxf); 2015 Jul; 83(1):124-32. PubMed ID: 25130203 [TBL] [Abstract][Full Text] [Related]
53. Contribution of computed tomography to ultrasound in predicting lateral lymph node metastasis in patients with papillary thyroid carcinoma. Yoon JH; Kim JY; Moon HJ; Youk JH; Son EJ; Kim EK; Han KH; Kwak JY Ann Surg Oncol; 2011 Jun; 18(6):1734-41. PubMed ID: 21369742 [TBL] [Abstract][Full Text] [Related]
54. Value of CT added to ultrasonography for the diagnosis of lymph node metastasis in patients with thyroid cancer. Lee Y; Kim JH; Baek JH; Jung SL; Park SW; Kim J; Yun TJ; Ha EJ; Lee KE; Kwon SY; Yang KS; Na DG Head Neck; 2018 Oct; 40(10):2137-2148. PubMed ID: 29756249 [TBL] [Abstract][Full Text] [Related]
55. Overcoming the limitations of fine needle aspiration biopsy: detection of lateral neck node metastasis in papillary thyroid carcinoma. Jun HH; Kim SM; Kim BW; Lee YS; Chang HS; Park CS Yonsei Med J; 2015 Jan; 56(1):182-8. PubMed ID: 25510763 [TBL] [Abstract][Full Text] [Related]
56. A comparison of the efficiency of diagnostic ultrasound and magnetic resonance imaging of cervical lymph nodes in papillary thyroid carcinoma. Iqbal MA; Wang X; Guoliang Z; Moazzam NF; Shahid AD; Qian X; Qian W J Xray Sci Technol; 2021; 29(6):1033-1044. PubMed ID: 34511478 [TBL] [Abstract][Full Text] [Related]
57. Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT. Choi JS; Kim J; Kwak JY; Kim MJ; Chang HS; Kim EK AJR Am J Roentgenol; 2009 Sep; 193(3):871-8. PubMed ID: 19696304 [TBL] [Abstract][Full Text] [Related]
58. [Risk factors for central neck lymph node metastases of papillary thyroid carcinoma]. Sun YS; Lyu HJ; Zhao YR; Zhang SS; Bai YX; Shi BY Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):421-425. PubMed ID: 28635213 [No Abstract] [Full Text] [Related]
59. Ultrasound lymphatic imaging for the diagnosis of metastatic central lymph nodes in papillary thyroid cancer. Liu Z; Wang R; Zhou J; Zheng Y; Dong Y; Luo T; Wang X; Zhan W Eur Radiol; 2021 Nov; 31(11):8458-8467. PubMed ID: 33881571 [TBL] [Abstract][Full Text] [Related]
60. A meta-analysis evaluating the relationship between B-type Raf kinase mutation and cervical lymphatic metastasis in papillary thyroid cancer. Ma H; Wang R; Fang J; Zhong Q; Chen X; Hou L; Feng L; Chen X; Huang Z; Zhao H Medicine (Baltimore); 2020 Jan; 99(5):e18917. PubMed ID: 32000400 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]